A survey of treatment practices in diabetic peripheral neuropathy☆

Received 15 May 2009; received in revised form 18 August 2009; accepted 25 August 2009. published online 05 October 2009.

Abstract

Objective

To evaluate provider practices for identification and treatment of painful diabetic peripheral neuropathy (DPN).

Methods

A questionnaire was distributed to healthcare providers attending educational programs in New England.

Results

The survey was completed by 357 providers. Although generally ineffective in neuropathic pain, non-steroidal anti-inflammatory drugs were prescribed by 31% of providers. Only 57% providers used a quantitative pain scale to evaluate pain. The effectiveness of medications was assessed at least frequently by 70% of providers and at every visit by 22% providers.

Conclusion

The results reiterate the need for routinely monitoring patients with painful DPN and using appropriate pain scales.

Keywords: Diabetic peripheral neuropathy, Provider survey, Treatment practices in neuropathic pain

a Pfizer, Inc., PO Box 1021, Jericho Center, VT 05465, United States

b University of Vermont, College of Medicine, 89 Beaumont Ave, Room C225 Given Building, Burlington, VT 05405, United States

Corresponding author. Tel.: +1 802 899 1146; fax: +1 802 899 1146.

☆ This project was presented as a poster at the American Academy of Pain Management's 19th Annual Clinical Meeting in Nashville, TN, September 2008.

1 Tel.: +1 802 656 4588.

PII: S1751-9918(09)00088-6

doi:10.1016/j.pcd.2009.08.008

12 of 14